Literature DB >> 25576171

A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery.

Eva Brillat1,2, Frédéric Rouberol3, Karine Palombi2, Jean-Louis Quesada1,4, Diane Bernheim2, Pierre Albaladejo1,5, Florent Aptel1,2, Jean-Paul Romanet1,2, Christophe Chiquet6,7.   

Abstract

PURPOSE: The purpose of this study was to evaluate the hemorrhagic risk factors during the management of primary rhegmatogenous retinal detachment (RD).
METHODS: Three hundred and twenty-two patients with (n = 74) or without (n = 248) bleeding (anterior segment, choroidal, intravitreal and/or subretinal) during or after RD surgery were included in this case-control study. Exclusion criteria were: history of trauma, vitreoretinal surgery, diabetic retinopathy, and taking clopidogrel and/or a vitamin K antagonist. Univariate and multivariate analyses were performed to identify risk factors of perioperative bleeding.
RESULTS: Aspirin was not significantly associated with bleeding complications during or after surgery (p = 0.8). Scleral buckling (with cryotherapy and gas tamponnade) was performed in 47 % of the cases and pars plana vitrectomy in 53 % of the cases. Independent risk factors of perioperative hemorrhage were the number of cryotherapy impacts (odds ratio =1.12 [1.06; 1.20], 95 % confidence interval), transscleral drainage (OR = 4.22 [1.62; 10.98]), and use of pars plana vitrectomy (OR = 3.39 [1.36; 8.47]). Bleeding complications were associated with a lower single-operation anatomical success rate (74 % vs 84 %, p = 0.03). There was also a trend toward an association between bleeding complications, a higher total number of RD recurrences (0.19 ± 0.5 in the non-bleeding group vs 0.34 ± 0.6, p = 0.06), and a lower final visual acuity (0.5 ± 0.6 logMAR vs 0.7 ± 0.7, p = 0.09).
CONCLUSION: This case-control study suggests that aspirin is not a major risk factor of hemorrhagic complications during and after RD surgery. Perioperative bleeding leads to a lower single-operation anatomic success rate.

Entities:  

Keywords:  Aspirin; Bleeding; Complication; Hemorrhage; Retinal detachment

Mesh:

Substances:

Year:  2015        PMID: 25576171     DOI: 10.1007/s00417-014-2900-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

Review 1.  Patients under anti-platelet therapy.

Authors:  Pierre Albaladejo; Charles Marc Samama
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2010-03

2.  Primary pars plana vitrectomy versus scleral buckle surgery for the treatment of pseudophakic retinal detachment: a randomized clinical trial.

Authors:  Periklis D Brazitikos; Sofia Androudi; William G Christen; Nikolaos Tr Stangos
Journal:  Retina       Date:  2005-12       Impact factor: 4.256

3.  Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force.

Authors:  P Albaladejo; E Marret; V Piriou; C-M Samama
Journal:  Br J Anaesth       Date:  2006-10       Impact factor: 9.166

4.  Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial.

Authors:  J Mantz; C M Samama; F Tubach; P J Devereaux; J-P Collet; P Albaladejo; B Cholley; R Nizard; J Barré; V Piriou; N Poirier; A Mignon; S Schlumberger; D Longrois; F Aubrun; M E Farèse; P Ravaud; P G Steg
Journal:  Br J Anaesth       Date:  2011-08-27       Impact factor: 9.166

5.  Does cryotherapy before drainage increase the risk of intraocular haemorrhage and affect outcome? A prospective, randomised, controlled study using a needle drainage technique and sustained ocular compression.

Authors:  I A Pearce; D Wong; J McGalliard; C Groenewald
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

6.  Perioperative choroidal hemorrhage at pars plana vitrectomy. A case-control study.

Authors:  J G Piper; D P Han; G W Abrams; W F Mieler
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

7.  Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.

Authors:  Marie Passemard; Philippe Koehrer; André Juniot; Alain M Bron; Catherine Creuzot-Garcher
Journal:  Retina       Date:  2012-10       Impact factor: 4.256

Review 8.  Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.

Authors:  Issam D Moussa; Antonio Colombo
Journal:  Catheter Cardiovasc Interv       Date:  2009-12-01       Impact factor: 2.692

9.  Needle drainage of subretinal fluid. A randomized clinical trial.

Authors:  R L Burton; J D Cairns; W G Campbell; W J Heriot; J B Heinze
Journal:  Retina       Date:  1993       Impact factor: 4.256

10.  Pseudophakic retinal detachment: anatomic and visual results.

Authors:  P Girard; I Karpouzas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-06       Impact factor: 3.117

View more
  4 in total

Review 1.  Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review.

Authors:  Rupa Patel; Stephen Charles; Assad Jalil
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-18       Impact factor: 3.117

Review 2.  Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review.

Authors:  A K Makuloluwa; S Tiew; M Briggs
Journal:  Eye (Lond)       Date:  2019-03-08       Impact factor: 3.775

3.  Perioperative Management of Antiplatelet Therapy in Ophthalmic Surgery.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2020

4.  Hemorrhagic complications associated with suprachoroidal buckling.

Authors:  Fares Antaki; Ali Dirani; Marina Ravagnani Ciongoli; David H W Steel; Flavio Rezende
Journal:  Int J Retina Vitreous       Date:  2020-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.